State Street Corp Neuro Pace Inc Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Neuro Pace Inc stock. As of the latest transaction made, State Street Corp holds 368,737 shares of NPCE stock, worth $3.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

368,737

Previous 171,855 114.56%

Holding current value

$3.37 Million

Previous $2.11 Million 94.46%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$10.34 - $18.13 $2.04 Million - $3.57 Million	196,882 Added 114.56%	368,737 $4.11 Million
Q1 2025 May 15, 2025	BUY	$10.04 - $14.94 $236,462 - $351,866	23,552 Added 15.88%	171,855 $2.11 Million
Q4 2024 Feb 14, 2025	SELL	$5.9 - $11.93 $42,403 - $85,740	-7,187 Reduced 4.62%	148,303 $1.66 Million
Q3 2024 Nov 14, 2024	BUY	$6.65 - $8.46 $85,864 - $109,235	12,912 Added 9.06%	155,490 $1.08 Million
Q2 2024 Aug 14, 2024	BUY	$6.38 - $15.33 $671,986 - $1.61 Million	105,327 Added 282.75%	142,578 $1.08 Million
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $38,142 - $68,250	3,900 Added 11.69%	37,251 $491,000
Q4 2023 Feb 14, 2024	BUY	$5.9 - $10.31 $590 - $1,031	100 Added 0.3%	33,351 $343,000
Q3 2023 Nov 14, 2023	BUY	$4.0 - $9.73 $43,200 - $105,084	10,800 Added 48.1%	33,251 $323,000
Q2 2022 Aug 15, 2022	SELL	$4.95 - $8.7 $377,516 - $663,514	-76,266 Reduced 77.26%	22,451 $111,000
Q1 2022 May 16, 2022	BUY	$7.06 - $11.57 $14,416 - $23,625	2,042 Added 2.11%	98,717 $810,000
Q4 2021 Feb 14, 2022	SELL	$8.63 - $17.36 $8,025 - $16,144	-930 Reduced 0.95%	96,675 $974,000
Q3 2021 Nov 15, 2021	BUY	$15.85 - $25.07 $393,064 - $621,710	24,799 Added 34.06%	97,605 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$19.03 - $26.5 $1.39 Million - $1.93 Million	72,806 New	72,806 $1.73 Million

Others Institutions Holding NPCE

# of Institutions

108

Shares Held

21.4M

Call Options Held

3.14M

Put Options Held

68.6K

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $227M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Neuro Pace Inc Transaction History